One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The Perils and Pitfalls of Global Engagement
Melody T. Asukile, MMed1; Deanna R. Saylor, MD1,2; Gretchen L. Birbeck, MD1,3
Looking Beyond Syndrome-Based Criteria for Autoimmune Encephalitis—The Need for Complementary Neural Antibody–Based Diagnostic Criteria
Adrian Budhram, MD1,2; Sarosh R. Irani, BMBCh, DPhil3,4; Eoin P. Flanagan, MBBCh5,6
Harnessing Brain Pathology for Dementia Prevention
Yue Leng, PhD1; Kristine Yaffe, MD1,2,3
Brainstem Encephalitis as a Cause of Sudden Infant Death Syndrome
Avindra Nath, MD1
Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia
Klodian Dhana, MD, PhD1,2; Puja Agarwal, PhD2,3; Bryan D. James, PhD2,3; Sue E. Leurgans, PhD3,4; Kumar B. Rajan, PhD1,2; Neelum T. Aggarwal, MD3,4; Lisa L. Barnes, PhD3,4; David A. Bennett, MD3,4; Julie A. Schneider, MD, MS3,4,5
Multiomic Analysis of Neuroinflammation and Occult Infection in Sudden Infant Death Syndrome
Prashanth S. Ramachandran, MBBS, PhD1,2,3,4; Benjamin W. Okaty, PhD5; Molly Riehs, BS6; Anne Wapniarski, BS1; Daniel Hershey, MD7; Hani Harb, PhD8,9; Maham Zia, BS1; Elisabeth A. Haas, MPH10; Sanda Alexandrescu, MD6; Lynn A. Sleeper, ScD11; Sara O. Vargas, MD6; Mark P. Gorman, MD12; Steven Campman, MD13; Othon J. Mena, MD13,16; Keith Levert, PhD14; Keith Hyland, PhD14; Richard D. Goldstein, MD15; Michael R. Wilson, MD1; Robin L. Haynes, PhD6
Risk of Stroke and Myocardial Infarction Among Initiators of Triptans
Christian Lund Petersen, MD1,2; Anders Hougaard, MD, PhD3,4; David Gaist, MD, PhD5; Jesper Hallas, MD, DMSc1,6
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
Nicholas J. Ashton, PhD1,2,3,4; Wagner S. Brum1,5; Guglielmo Di Molfetta, MSc1; Andrea L. Benedet, PhD1; Burak Arslan, MD1; Erin Jonaitis, PhD6,7,8; Rebecca E. Langhough, PhD6,7,8; Karly Cody, PhD7; Rachael Wilson, PhD7,8; Cynthia M. Carlsson, PhD6,7,8,9; Eugeen Vanmechelen, PhD10; Laia Montoliu-Gaya, PhD1; Juan Lantero-Rodriguez, PhD1; Nesrine Rahmouni, MSc11,12; Cecile Tissot, PhD11,12; Jenna Stevenson, PhD11,12; Stijn Servaes, PhD11,12; Joseph Therriault, PhD11,12; Tharick Pascoal, MD, PhD13,14; Alberto Lleó, MD, PhD15,16; Daniel Alcolea, MD, PhD15,16; Juan Fortea, MD, PhD15,16; Pedro Rosa-Neto, MD, PhD11,12; Sterling Johnson, MD, PhD6,7; Andreas Jeromin, PhD17; Kaj Blennow, MD, PhD1,18; Henrik Zetterberg, MD, PhD1,7,18,19,20,21
Endovascular Treatment of Acute Ischemic Stroke After Cardiac Interventions in the United States
Adam de Havenon, MD, MS1; Lily W. Zhou, MD, MS2; Andrew B. Koo, MD3; Charles Matouk, MD3; Guido J. Falcone, MD, ScD, MPH1; Richa Sharma, MD, MPH1; John Ney, MD, MPH4; Liqi Shu, MD5; Shadi Yaghi, MD5; Hooman Kamel, MD, MS6,7; Kevin N. Sheth, MD1
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis
Nail Benallegue, MD, PhD1,2; Fabien Rollot, MSc3,4,5,6; Sandrine Wiertlewski, MD2,7; Romain Casey, PhD3,4,5,6; Marc Debouverie, MD, PhD8; Anne Kerbrat, MD, PhD9; Jérôme De Seze, MD, PhD10; Jonathan Ciron, MD11,12; Aurelie Ruet, MD, PhD13,14; Pierre Labauge, MD, PhD15; Elisabeth Maillart, MD16; Helene Zephir, MD, PhD17; Caroline Papeix, MD, PhD18; Gilles Defer, MD19; Christine Lebrun-Frenay, MD, PhD20; Thibault Moreau, MD, PhD21; Eric Berger, MD22; Bruno Stankoff, MD, PhD23; Pierre Clavelou, MD, PhD24; Olivier Heinzlef, MD25; Jean Pelletier, MD, PhD26; Eric Thouvenot, MD, PhD27,28; Abdullatif Al Khedr, MD29; Bertrand Bourre, MD30; Olivier Casez, MD31; Philippe Cabre, MD, PhD32; Abir Wahab, MD33; Laurent Magy, MD, PhD34; Sandra Vukusic, MD, PhD3,4,5,6; David-Axel Laplaud, MD, PhD2,7; for the OFSEP (Observatoire Français de la Sclérose en Plaques) Investigators
Building CRISPR Gene Therapies for the Central Nervous System
Sally E. Salomonsson, PhD1,2; Claire D. Clelland, PhD, MD1,2
Punctate Diffuse Cortex Signals in Creutzfeldt-Jakob Disease
Zhongyun Chen, MD1; Yu Kong, MD1; Liyong Wu, MD, PhD1
Trigeminal Ganglionopathy on Brain Magnetic Resonance Imaging—A Rare Etiology
Noel William Gomes, MBBS, MD1; Rahul Tryambak Chakor, MBBS, MD, DM1; Swaleha Nadaf, MBBS, MD, DM1
Concomitant Medications for Progressive Supranuclear Palsy
Jay M. Iyer1; Douglas Gunzler, PhD2; Anthony E. Lang, MD3; Lawrence I. Golbe, MD4; Alexander Pantelyat, MD5; Adam L. Boxer, MD, PhD6; Anne-Marie Wills, MD, MPH7; for the AL-108-231 Study Group
MOG-IgA as a Potential Marker of Germinal Center Activity
Adam E. Handel, DPhil1,2; Sarosh R. Irani, DPhil3; M. Isabel Leite, DPhil1,2
MOG-IgA as a Potential Marker of Germinal Center Activity—Reply
Laila Kulsvehagen, MSc1,2,3; Ana Beatriz Ayroza Galvão Ribeiro Gomes, MD1,2,3,4; Anne-Katrin Pröbstel, MD1,2,3
